Premenstrual syndrome: Advances in diagnosis and treatment

Obstetrics and Gynecology Clinics of North America

Volumn 27, Issue 3, 2000, Pages 625-639

  Kessel, Bruce ^b  

^a Queen Emma Outpatient Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; CLOMIPRAMINE; GONADORELIN DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

DIFFERENTIAL DIAGNOSIS; HORMONE SUBSTITUTION; HUMAN; PATHOPHYSIOLOGY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0033847721     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70160-1     Document Type: Article

References (50)

1. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample
2. Cognitive therapy for premenstrual syndrome: A controlled trial
3. Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls
4. Management of menstrual migraine
5. Buspirone in the treatment of premenstrual syndrome
6. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome
7. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine
8. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome
9. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome
10. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
11. Fluvoxamine for premenstrual dysphoric disorder: A pilot study
12. Alleviation of premenstrual syndrome symptoms with the relaxation response
13. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive
14. The premenstrual syndrome
15. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
16. Continuous bromocriptine therapy in menstrual migraine
17. Cross cultural study of premenstrual symptoms
18. The epidemiology and social impact of premenstrual symptoms
19. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression
20. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia
21. A controlled study of light therapy in women with late luteal phase dysphoric disorder
22. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome
23. Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome
24. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin
25. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences
26. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and add-back therapy
27. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol
28. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
29. Conditioning exercise decreases premenstrual symptoms: A prospective controlled three-month trial
30. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women
31. Progesterone metabolite allopregnanolone in women with premenstrual syndrome
32. Premenstrual syndrome
33. Late luteal phase dysphoric disorder in young women
34. Implications of endocrine studies in premenstrual syndrome
35. The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome
36. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
37. Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial
38. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria
39. Fluoxetine in the treatment of premenstrual dysphoria
40. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls
41. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial
42. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms
43. Magnesium supplementation alleviates premenstrual symptoms of fluid retention
44. Treatment of premenstrual syndrome by spironolactone: A double-blind, placebo-controlled study
45. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
46. Mental, behavioral and developmental disorders
47. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review
48. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial
49. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial